Simris Group AB
556841-9187ActivePioneering next-generation ADC payloads using proprietary cyanobacterial science.
Oversigt
- 5–9
- Medarbejdere
- 150–199t SEK
- Omsætning
- 2011
- Grundlagt
Beskrivelse
Simris is a biotechnology company dedicated to revolutionizing cancer treatment through its proprietary pipeline of next-generation ADC payloads. These payloads are born from world-class cyanobacterial science, proprietary conjugation methods, and collaborations with leading research institutions. T...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Fiskodling i saltvatten
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556841918701
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Nanohumps Biosciences Oy
Pioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Xbrane Biopharma AB
20–49 medarbejdereDeveloping cost-effective biosimilars using proprietary platform technology.
Alvotech Sweden AB
20–49 medarbejdereDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Abarceo Pharma AB
5–9 medarbejdereDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
Udforsk mere
Spørgsmål om Simris Group AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo